Care Management MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy Mode of DeliveryBy End-useBy ApplicationBy Enterprise Size

Care management platforms and services help health plans and provider organizations track, coordinate and intervene in the ongoing treatment of patients with chronic conditions or complex care needs, combining case management, utilization review and remote monitoring functions into a single workflow. They are delivered as standalone software, cloud-hosted platforms, or bundled with implementation, training and ongoing support services. Buyers are hospital systems, physician groups, health insurers and, to a lesser extent, employers and government payers seeking to reduce avoidable admissions and manage the cost of high-need patient populations.

The care management market care management market stood at USD 18.5 billion in 2025. A forecast-period rate of 15% takes it to USD 64.24 billion by 2034, and the study reports every year in between, passing USD 8.2 billion in 2020, USD 15.7 billion in 2024, USD 21 billion in 2026 and USD 36.73 billion in 2030.

Composition changes more than the total does. Software, at 17.85%, outgrows Services at 11.66%, and its share moves from 48% to 60%. Services stays the largest line throughout, at USD 9.62 billion in 2025 and USD 25.7 billion in 2034. Software take share over the period; Services give it up while still growing in absolute terms.

By mode of delivery, Cloud-based accounts for 55% of 2025 revenue at USD 10.18 billion, reaching USD 43.68 billion and 68% by 2034. It is also the fastest-growing line on this axis at 17.57%, so the split concentrates rather than balances over the period. This axis divides the same revenue as the component split rather than adding to it, so the two are read together rather than summed.

Geographically, 45% of 2025 revenue sits in North America (USD 8.33 billion rising to USD 25.7 billion) ahead of Europe at 25% and USD 4.63 billion. Middle East and Africa is smallest, at 4%. Share shifts toward Asia Pacific, Latin America and Middle East and Africa over the forecast period, which is what makes the regional split worth reading rather than assuming.

Coverage extends to five regions, two component lines and five segmentation axes over the full fifteen years. The 2025 total itself is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the splits below are estimated on that same basis, a bound on their precision worth carrying into any use of them.

• Revenue grows from USD 18.5 billion in 2025 to USD 64.24 billion in 2034, a compound annual rate of 15%, having reached USD 15.7 billion in 2024 from USD 8.2 billion in 2020.
• 52% of 2025 revenue sits in Services (USD 9.62 billion) and it remains the largest component line in 2034 at USD 25.7 billion and 40%.
• At 17.85%, Software grows faster than any other component line, moving from USD 8.88 billion and 48% of revenue in 2025 to USD 38.54 billion and 60% in 2034.
• Against a base case of USD 64.24 billion in 2034, the study also reports a bear case at USD 52.01 billion and a bull case at USD 78.94 billion, with the assumptions behind each set out separately.
• 45% of 2025 revenue is generated in North America, worth USD 8.33 billion and rising to USD 25.7 billion by 2034; Middle East and Africa is smallest at 4%.
• 85% of North America's base-year revenue comes from the United States alone: USD 7.08 billion in 2025, rising to USD 21.84 billion by 2034, which is why it is that region's worked example.
• Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region rather than a single blended series.

The care management market care management market is shaped over 2026-2034 by three measurable movements: a change in the component mix, a shift in where revenue sits geographically, and the 15% rate carrying the total.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; the question is which takes the larger part of the growth.

Composition shifts on the component axis. Software grows at 17.85% across 2026-2034 against 11.66% for Services, the widest spread on the component axis. By 2034 the two sit at 60% and 40% of revenue, against 48% and 52% in 2025. In absolute terms Software rises from USD 8.88 billion to USD 38.54 billion, while Services rises from USD 9.62 billion to USD 25.7 billion. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.

Growth concentrates in Asia Pacific, Latin America and Middle East and Africa. Asia Pacific moves from 20% of revenue in 2025 to 26% in 2034, worth USD 3.7 billion rising to USD 16.7 billion; Latin America moves from 6% of revenue in 2025 to 6.5% in 2034, worth USD 1.11 billion rising to USD 4.18 billion; Middle East and Africa moves from 4% of revenue in 2025 to 4.5% in 2034, worth USD 0.74 billion rising to USD 2.89 billion. Against that, North America at 45% moving to 40%, Europe at 25% moving to 23%, a fall in share, not in revenue. That makes the regional split worth reading rather than scaling from the global rate: the same market rate produces different outcomes depending on where a supplier's revenue sits.

Growth compounds at 15% without a step change. Reading the series: USD 8.2 billion in 2020, USD 15.7 billion in 2024, USD 18.5 billion in 2025, USD 21 billion in 2026, USD 36.73 billion in 2030 and USD 64.24 billion in 2034. Against 17.67% through the historical period, the 15% forecast rate is a continuation; no year in the series interrupts it. A plan built on this market is therefore a plan about capturing a share of steady expansion, which is decided on the component and regional axes, not by the headline rate.

Software carries the market's growth rate

The 15% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the component axis, and where regional growth is concentrated.

The bear case and what drives it

Upside case: USD 78.94 billion by 2034

One component line carries the market

In North America, 45% of global revenue puts 2025 at USD 8.33 billion on the way to USD 25.7 billion by 2034. That makes it the first-largest region covered, in 2025 and again in 2034.

By 2034 the share stands at 40%, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

The component mix reported at global level applies here, with Services the largest line at 52% of 2025 revenue and Software the fastest-growing at 17.85%. North America is reported axis by axis and country by country in the full study.

The United States is the largest market within North America, generating USD 7.08 billion in 2025 and projected to reach USD 21.84 billion by 2034. Because it is 85% of the region in the base year, North America's totals move with this one country rather than with a spread of them. The region itself runs USD 8.33 billion to USD 25.7 billion over the same period, and this is the market carrying the country-level detail in the full report.

Composition here matches the global split: the largest line is Services at 52% of 2025 revenue, easing to 40% by 2034, and the fastest is Software at 17.85%, from 48% to 60%. With 85% of North America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by component for the United States is reported separately in the full report.

Care management offerings in the United States sit at the intersection of health data privacy law and clinical software oversight. Any platform handling protected health information must meet the Health Insurance Portability and Accountability Act's privacy and security rules, and vendors typically undergo business associate agreements with covered entities. Where a care management program is billed as a reimbursable service, providers must satisfy the Centers for Medicare and Medicaid Services' documentation and care-coordination requirements. If a platform's decision-support features cross into diagnostic or treatment recommendations, oversight can extend to the Food and Drug Administration's software-as-a-medical-device framework, though most care coordination and population health tools stay outside that pathway and rely instead on health-IT certification standards administered under the ONC Health IT Certification Program.

In the United States the field is Allscripts Healthcare, LLC, Epic Systems Corp., Cognizant, ExlService Holdings, Inc., Koninklijke Philips N.V., Cerner Corp. (Oracle), ZeOmega, Medecision, IBM, Optum, Inc., NantHealth, Inc., Innovaccer Inc., Health Catalyst, Inc. and Conduent Incorporated. Two different problems sit on the same axis: holding Services at 52% of 2025 revenue, and taking Software while it grows at 17.85%. Country-level positioning and shares for each of these companies are part of the full report rather than this summary.

Canada is sized at USD 1.25 billion in 2025, rising to USD 3.85 billion by 2034; 6.75% of global revenue and 15% of North America. It is reported separately from the United States across every segmentation axis in the full report.

USD 4.63 billion of 2025 revenue is generated in Europe, 25% of the care management market care management market and reaches USD 14.78 billion by 2034. It is a leading region on this axis, second by revenue throughout the period.

23% of global revenue sits here in 2034, below the 2025 level, though revenue still rises throughout; what changes is the region's weight against faster-growing ones, which is not the same as weakening demand.

Within the region the component split tracks the global one; 52% of 2025 revenue in Services, fastest growth of 17.85% in Software. The full report breaks Europe out along every axis and by country.

The largest single market in Europe is Germany, at USD 1.48 billion in 2025 and USD 4.73 billion in 2034. 32% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 4.63 billion to USD 14.78 billion over the same period, and this is the market carrying the country-level detail in the full report.

Germany buys along the same lines as the market globally; Services first at 52% of 2025 revenue and 40% in 2034, Software fastest at 17.85% on a share moving from 48% to 60%. With 32% of Europe concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports Germany by component separately.

In Germany, care management platforms are regulated according to their clinical function. A tool that supports diagnosis, monitoring, or treatment decisions can qualify as a medical device under the EU Medical Device Regulation, requiring conformity assessment and CE marking before market entry. Digital health applications intended for patient-facing therapeutic or monitoring use may instead pursue listing on the national Digitale Gesundheitsanwendungen fast-track register overseen by the Federal Institute for Drugs and Medical Devices, which reviews safety, functionality, and data security. Regardless of classification route, any platform processing patient data must comply with the General Data Protection Regulation and Germany's own social code provisions governing confidentiality of health information held by care providers and insurers.

In Germany the field is Allscripts Healthcare, LLC, Epic Systems Corp., Cognizant, ExlService Holdings, Inc., Koninklijke Philips N.V., Cerner Corp. (Oracle), ZeOmega, Medecision, IBM, Optum, Inc., NantHealth, Inc., Innovaccer Inc., Health Catalyst, Inc. and Conduent Incorporated. Volume sits in Services at 52% of 2025 revenue; movement sits in Software at 17.85% growth.

The United Kingdom is sized at USD 1.3 billion in 2025, rising to USD 4.14 billion by 2034; 7% of global revenue and 28% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

France is sized at USD 0.93 billion in 2025, rising to USD 2.96 billion by 2034; 5% of global revenue and 20% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

In Asia Pacific, 20% of global revenue puts 2025 at USD 3.7 billion with USD 16.7 billion projected for 2034. By revenue it sits third across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share has moved up to 26%, at a pace above the 15% global rate, which is what makes this region worth reading separately rather than scaling from the total.

Segment composition follows the global pattern: Services largest at 52% of 2025 revenue, Software fastest at 17.85%. The full report breaks Asia Pacific out along every axis and by country.

35% of Asia Pacific's base-year revenue comes from China; USD 1.3 billion, rising to USD 5.85 billion by 2034. Its 35% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Regional revenue of USD 3.7 billion in 2025 and USD 16.7 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

China buys along the same lines as the market globally; Services first at 52% of 2025 revenue and 40% in 2034, Software fastest at 17.85% on a share moving from 48% to 60%. With 35% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The full report reports China by component separately.

Care management software distributed in China falls under the National Medical Products Administration's oversight where its functions support diagnosis, treatment, or clinical decision-making, requiring registration as software classified by risk category before it can be marketed. Platforms that stop at administrative coordination, scheduling, or non-clinical case tracking generally sit outside medical device registration but must still meet cybersecurity and data-localization obligations under China's Cybersecurity Law and Personal Information Protection Law, particularly where patient health data is collected, stored, or transferred. The National Health Commission also issues sector guidance on how hospitals and insurers may adopt digital care coordination tools, shaping procurement even where formal device registration does not apply.

Competition in China runs between the suppliers this study tracks: Allscripts Healthcare, LLC, Epic Systems Corp., Cognizant, ExlService Holdings, Inc., Koninklijke Philips N.V., Cerner Corp. (Oracle), ZeOmega, Medecision, IBM, Optum, Inc., NantHealth, Inc., Innovaccer Inc., Health Catalyst, Inc. and Conduent Incorporated. Volume sits in Services at 52% of 2025 revenue; movement sits in Software at 17.85% growth.

5% of global revenue is generated in Japan; USD 0.93 billion in 2025, reaching USD 4.18 billion in 2034, and 25% of Asia Pacific.

Within Asia Pacific, India accounts for 18% of regional revenue and 3.6% of the global total, worth USD 0.67 billion in 2025 and USD 3.01 billion by 2034.

USD 1.11 billion of 2025 revenue is generated in Latin America, 6% of the care management market care management market rising to USD 4.18 billion in 2034. By revenue it sits fourth across the study, and the ranking does not change between 2025 and 2034.

Share climbs to 6.5% by 2034, so the region grows faster than the market's 15% and takes a larger part of the revenue added by 2034 than its 2025 weight implies.

The component mix reported at global level applies here, with Services the largest line at 52% of 2025 revenue and Software the fastest-growing at 17.85%. The full report breaks Latin America out along every axis and by country.

USD 0.61 billion of Latin America's 2025 revenue is generated in Brazil, the region's largest market, reaching USD 2.3 billion by 2034. At 55% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. The region itself runs USD 1.11 billion to USD 4.18 billion over the same period, and this is the market carrying the country-level detail in the full report.

The component pattern in Brazil is the global one: 52% of 2025 revenue in Services, 40% by 2034, against 17.85% growth in Software taking it from 48% to 60%. Since 55% of Latin America's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Brazil carries its own component breakdown in the full report.

In Brazil, care management platforms with a genuine clinical purpose, such as remote monitoring or treatment support, are regulated by the National Health Surveillance Agency as software-based medical devices, requiring registration and adherence to its quality and risk-classification requirements. Tools limited to administrative case coordination or population health analytics generally fall outside that regime but remain subject to the General Data Protection Law, which governs consent, storage, and transfer of patient information. Where care management services are delivered within the public health system, providers must also align with Ministry of Health interoperability and data-reporting standards that shape how such platforms are procured and integrated into public care pathways.

Competition in Brazil runs between the suppliers this study tracks: Allscripts Healthcare, LLC, Epic Systems Corp., Cognizant, ExlService Holdings, Inc., Koninklijke Philips N.V., Cerner Corp. (Oracle), ZeOmega, Medecision, IBM, Optum, Inc., NantHealth, Inc., Innovaccer Inc., Health Catalyst, Inc. and Conduent Incorporated. The commercially relevant division is 52% of 2025 revenue in Services, where the volume is, against 17.85% growth in Software, where share moves.

1.8% of global revenue is generated in Mexico; USD 0.33 billion in 2025, reaching USD 1.25 billion in 2034, and 30% of Latin America.

Middle East and Africa holds 4% of the care management market care management market in 2025, worth USD 0.74 billion with USD 2.89 billion projected for 2034. Among the five regions it ranks fifth by revenue in both years.

4.5% of global revenue sits here by 2034, up from the 2025 level, because it outgrows the market's 15%; the revenue added here is disproportionate to where the region started.

Services leads here as it does globally, at 52% of 2025 revenue, and Software again grows fastest at 17.85%. Middle East and Africa is reported axis by axis and country by country in the full study.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 0.33 billion in 2025 and USD 1.3 billion in 2034. It accounts for 45% of regional revenue in the base year, the largest single share without dominating the region outright. Regional revenue of USD 0.74 billion in 2025 and USD 2.89 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Saudi Arabia buys along the same lines as the market globally; Services first at 52% of 2025 revenue and 40% in 2034, Software fastest at 17.85% on a share moving from 48% to 60%. With 45% of Middle East and Africa concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by component for Saudi Arabia is reported separately in the full report.

In Saudi Arabia, care management solutions that perform a clinical function are regulated by the Saudi Food and Drug Authority under its medical device framework, which requires registration and conformity to its software-as-a-medical-device requirements before distribution. Platforms used purely for administrative coordination or reporting typically fall outside device registration but must still meet the requirements of the national Personal Data Protection Law governing collection and handling of patient information. Healthcare facilities adopting such platforms are also expected to align with accreditation standards set by the Saudi Central Board for Accreditation of Healthcare Institutions, which addresses care coordination processes and information governance as part of facility-level quality requirements.

Competition in Saudi Arabia runs between the suppliers this study tracks: Allscripts Healthcare, LLC, Epic Systems Corp., Cognizant, ExlService Holdings, Inc., Koninklijke Philips N.V., Cerner Corp. (Oracle), ZeOmega, Medecision, IBM, Optum, Inc., NantHealth, Inc., Innovaccer Inc., Health Catalyst, Inc. and Conduent Incorporated. The commercially relevant division is 52% of 2025 revenue in Services, where the volume is, against 17.85% growth in Software, where share moves.

Within Middle East and Africa, the United Arab Emirates accounts for 30% of regional revenue and 1.2% of the global total, worth USD 0.22 billion in 2025 and USD 0.87 billion by 2034.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Component, Mode of Delivery, End-use, Application, Enterprise Size, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.